Register to get unlimited Level 2

Company Announcements

End of Stabilisation Notice

Related Companies

By LSE RNS

RNS Number : 8802Z
Arix Bioscience Plc
20 March 2017
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA, JAPAN, NEW ZEALAND, THE REPUBLIC OF IRELAND OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTIONS WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

20th March 2017

End of Stabilisation Notice

Arix Bioscience Plc (the "Company")

Pursuant to Article 6(3) of Commission Regulation (EC) 2016/1052 supplementing Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation, Jefferies International Limited (contact: Luca Erpici +44 (0)20 7029 8415; Lee Morton +44 (0)20 7029 8753) hereby gives notice that stabilisation was undertaken by the Stabilising Manager named below in relation to the offer of the following securities.

Issuer:

Arix Bioscience Plc

Securities:

Ordinary Shares (ISIN: GB00BD045071)

Description of Offer:

Initial Public Offering

Offer Price:

207p per ordinary share

Market:

London Stock Exchange, BATS, Chi-X, Turquoise

Ticker:

ARIX

Stabilising Manager:

Jefferies International Limited

Stabilisation Period:

17th February 2017 - 17th March 2017

 

Date

Lowest Price (pence)

Highest Price (pence)

 

Execution Venue

 

20/02/2017

205

207

London Stock Exchange

21/02/2017

206

207

London Stock Exchange

22/02/2017

207

207

London Stock Exchange

24/02/2017

207

207

London Stock Exchange

02/03/2017

207

207

London Stock Exchange

03/03/2017

207

207

London Stock Exchange

07/03/2017

206

207

London Stock Exchange, BATS, Chi-X, Turquoise

08/03/2017

207

207

London Stock Exchange

09/03/2017

207

207

London Stock Exchange

13/03/2017

207

207

London Stock Exchange

16/03/2017

206

207

London Stock Exchange, BATS, Chi-X, Turquoise

17/03/2017

207

207

London Stock Exchange

 

Disclaimer:

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction. The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

This announcement and copies of this announcement are not being made and may not be distributed, published, or sent, directly or indirectly, in whole or in part, in or into the United States, Australia, Canada, South Africa or Japan or to any persons in any of those jurisdictions or any other jurisdictions where to do so would be unlawful or would require registration or other measures. The release, publication or distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions.

The Offer and the distribution of this announcement and other information in connection with the listing and Offer in certain jurisdictions may be restricted by law and persons into whose possession this announcement, any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement is not and does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase any securities in the United States, Australia, Canada, Japan, South Africa or any other jurisdiction where such an offer would be unlawful.

The Securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "US Securities Act") or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered, sold, pledged or otherwise transferred within the United States absent registration or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and in compliance with any applicable laws of any state or other jurisdiction of the United States. The securities are being offered and sold outside the United States in offshore transactions as defined in, and in compliance with, Regulation S under the US Securities Act or within the United States only to "Qualified Institutional Buyers" ("QIBS") as defined in Rule 144A under the US Securities Act ("Rule 144"), who are also, in each case, "Qualified Purchasers" ("QPs"), as defined in section 2(a)(51) of the Investment Act of 1940, as amended (the "Investment Company Act"), or pursuant to another exemption form, or in a transaction not subject to, the registration requirements of the US Securities Act. Any forwarding, distribution or reproduction of this announcement, the publication in which it is contained and any copy of it in whole or in part is unauthorised.  Failure to comply with this notice may result in a violation of the US Securities Act or the applicable laws or other jurisdictions. This announcement does not contain or constitute an offer to buy or subscribe for, the securities referred to herein to any person in any jurisdiction where it is unlawful to do so. The Company does not intend to register any part of the Offer in the United States and there will be no public offering of securities in the United States.

The Securities have not been and will not be registered under the applicable securities laws of Canada, Japan, South Africa or Australia and may not be offered or sold in Canada, Japan, South Africa or Australia except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the applicable securities laws. There will be no public offering of securities in Canada, Japan, South Africa or Australia.

This announcement is only addressed to, and directed at, persons in member states of the European Economic Area who are "qualified investors" within the meaning of Article 2(1)(e) of the Prospectus Directive ("Qualified Investors"). For the purposes of this provision, the expression "Prospectus Directive" means Directive 2003/71/EC (as amended) and includes any relevant implementing measure in each member state of the European Economic Area which has implemented the Prospectus Directive. In addition, in the United Kingdom, this announcement is being distributed only to, and is directed only at, Qualified Investors (i) who have professional experience in matters relating to investments who fall within the definition of "investment professional" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), or (ii) who are high net worth companies, unincorporated associations and partnerships and trustees of high value trusts or other persons to whom it may otherwise lawfully be communicated falling within Article 49(2)(a)-(d) of the Order, (all such persons together being referred to as "relevant persons"). Any investment or investment activity to which this announcement relates is available only to and will only be engaged in with such persons. This announcement must not be acted on or relied on (i) in the United Kingdom, by persons who are not relevant persons; and (ii) in any member state of the European Economic Area other than the United Kingdom, by persons who are not Qualified Investors.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STADXGDXISBBGRC

Top of Page